The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA).
 
Susan Marina Chang
Research Funding - Novartis (Inst); Quest diagnostics (Inst); Schering-Plough Research Institute (Inst)
 
Peixin Zhang
No Relationships to Disclose
 
J. Gregory Cairncross
No Relationships to Disclose
 
Mark R. Gilbert
Honoraria - Abbvie; Cell Medica; Genentech/Roche; HERON; Merck; Wellcome Trust
Consulting or Advisory Role - Abbvie; Cell Medica; Genentech/Roche; HERON; Merck/Schering Plough; Wellcome Trust
Research Funding - Genentech/Roche; GlaxoSmithKline; Merck/Schering Plough
Travel, Accommodations, Expenses - Abbvie; Genentech/Roche; Merck/Schering Plough
 
Jean-Paul Bahary
No Relationships to Disclose
 
Carol Dolinskas
No Relationships to Disclose
 
Kenneth D. Aldape
No Relationships to Disclose
 
Arnab Chakravarti
No Relationships to Disclose
 
David Schiff
No Relationships to Disclose
 
Kurt A. Jaeckle
No Relationships to Disclose
 
Paul D. Brown
No Relationships to Disclose
 
Geoffrey Barger
No Relationships to Disclose
 
Maria Werner-Wasik
No Relationships to Disclose
 
Helen Alice Shih
No Relationships to Disclose
 
David Brachman
No Relationships to Disclose
 
Marta Penas-Prado
Research Funding - Bayer (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
H. Ian Robins
Consulting or Advisory Role - Schering-Plough
Research Funding - Schering-Plough (Inst)
 
Karl Belanger
No Relationships to Disclose
 
Christopher J. Schultz
No Relationships to Disclose
 
Minesh P. Mehta
Leadership - Pharmacyclics
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Ca Progress; Elekta; EMD Serono; Research to Practice
Consulting or Advisory Role - Abbvie; Best Medical Opinion; Bristol-Myers Squibb; Celldex; Gerson Lehrman Group; MedaCorp; Medical Director Solutions; Novelos; Novocure; Philips Healthcare; Roche/Genentech; Strategic Edge; US Oncology
Research Funding - Novelos (Inst); Novocure (Inst)